Ron Graybill

Ron Graybill is an accomplished executive in the pharmaceutical industry with extensive experience in market access and strategic leadership. Currently serving as Vice President of Market Access at Genmab since December 2020, Graybill has played a crucial role in establishing a successful US commercial organization. Prior to Genmab, Graybill held the position of Senior Vice President of Value and Access at Ipsen, where efforts contributed to a significant turnaround of the US business. Previous roles include Vice President of Managed Markets at Mylan Specialty and various leadership positions at Bayer HealthCare, Novartis, and Hoechst-Roussel Pharmaceuticals, showcasing a robust background in securing market access, profitability, and contracting strategies. Education includes a BS in Economics from Rutgers University and an MBA in Finance from Fairleigh Dickinson University.